These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 30855361)

  • 1. Emergence, development, and future of cardio-oncology in China: cardiohypersensitivity, cardiotoxicity and the Kounis syndrome.
    Kounis NG; Koniari I; Plotas P; Soufras GD; Tsigkas G; Davlouros P; Hahalis G
    Chin Med J (Engl); 2019 Mar; 132(6):753-754. PubMed ID: 30855361
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of gemcitabine in patients with squamous cell carcinoma of the cervix: a Phase II study of the gynecologic oncology group.
    Schilder RJ; Blessing JA; Morgan M; Mangan CE; Rader JS
    Gynecol Oncol; 2000 Feb; 76(2):204-7. PubMed ID: 10637071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcomes of gemcitabine and cisplatin in patients with recurrent or metastatic esophageal squamous cell carcinoma: a phase II trial.
    Huang J; Fan QX; Chen L; Liu AN; Cai RG; Hao XZ; Wang JW; Sun Y
    Chin Med J (Engl); 2011 Dec; 124(23):4012-7. PubMed ID: 22340334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Afatinib as First-line Treatment of Older Patients With EGFR Mutation-Positive Non-Small-Cell Lung Cancer: Subgroup Analyses of the LUX-Lung 3, LUX-Lung 6, and LUX-Lung 7 Trials.
    Wu YL; Sequist LV; Tan EH; Geater SL; Orlov S; Zhang L; Lee KH; Tsai CM; Kato T; Barrios CH; Schuler M; Hirsh V; Yamamoto N; O'Byrne K; Boyer M; Mok T; Peil B; Märten A; Chih-Hsin Yang J; Paz-Ares L; Park K
    Clin Lung Cancer; 2018 Jul; 19(4):e465-e479. PubMed ID: 29653820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of DNA translesion synthesis polymerase η in head and neck squamous cell cancer predicts resistance to gemcitabine and cisplatin-based chemotherapy.
    Zhou W; Chen YW; Liu X; Chu P; Loria S; Wang Y; Yen Y; Chou KM
    PLoS One; 2013; 8(12):e83978. PubMed ID: 24376779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternating chemotherapy: gemcitabine and cisplatin with concurrent radiotherapy for treatment of advanced head and neck cancer.
    Aguilar-Ponce JL; Granados-García M; Cruz López JC; Maldonado-Magos F; Alvarez-Avitia MA; Arrieta O; González-Ramírez I; Lara-Cruz G; Martinez-Juárez I; Medina-Santillan R; Castillo-Hernández C; De la Garza-Salazar J
    Oral Oncol; 2013 Mar; 49(3):249-54. PubMed ID: 23043985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gemcitabine and cisplatin as neoadjuvant chemotherapy for invasive transitional and squamous cell carcinoma of the bladder: effect on survival and bladder preservation.
    Khaled HM; Shafik HE; Zabhloul MS; Ghoneim M; Saber RA; Manie M; Enein HA; Megeed HA; Mansur O; Sherbini ME; Mahran TZ; Kalawee ME; Badran A; Ramadan SM
    Clin Genitourin Cancer; 2014 Oct; 12(5):e233-40. PubMed ID: 24889794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Safety of Necitumumab Continuation Therapy in the Phase III SQUIRE Study of Patients With Stage IV Squamous Non-Small-Cell Lung Cancer.
    Ciuleanu T; Socinski MA; Obasaju C; Luft AV; Szczesna A; Szafrański W; Ramlau R; Bálint B; Molinier O; Depenbrock H; Nanda S; Paz-Ares L; Thatcher N
    Clin Lung Cancer; 2018 Mar; 19(2):130-138.e2. PubMed ID: 29158123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial.
    Wu YL; Zhou C; Hu CP; Feng J; Lu S; Huang Y; Li W; Hou M; Shi JH; Lee KY; Xu CR; Massey D; Kim M; Shi Y; Geater SL
    Lancet Oncol; 2014 Feb; 15(2):213-22. PubMed ID: 24439929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Oncology--a common language, new perspectives. Lilly Oncology Global Medical Conference, Indianapolis, 1996].
    Pneumologie; 1996 Sep; 50(9 Suppl):1-12. PubMed ID: 9022416
    [No Abstract]   [Full Text] [Related]  

  • 11. A randomized trial comparing concurrent chemoradiotherapy with single-agent cisplatin versus cisplatin plus gemcitabine in patients with advanced cervical cancer: An Asian Gynecologic Oncology Group study.
    Wang CC; Chou HH; Yang LY; Lin H; Liou WS; Tseng CW; Liu FY; Liou JD; Huang KG; Huang HJ; Huang EY; Chen CH; Chang TC; Chang CJ; Hong JH; Lai CH
    Gynecol Oncol; 2015 Jun; 137(3):462-7. PubMed ID: 25827291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [IgG1 antibody allows the first targeted therapy].
    Einecke D
    MMW Fortschr Med; 2016 May; 158(9):70. PubMed ID: 27155719
    [No Abstract]   [Full Text] [Related]  

  • 13. A phase I-II study of weekly cisplatin and gemcitabine with concurrent radiotherapy in locally advanced cervical carcinoma.
    Zarbá JJ; Jaremtchuk AV; Gonzalez Jazey P; Keropian M; Castagnino R; Mina C; Arroyo G;
    Ann Oncol; 2003 Aug; 14(8):1285-90. PubMed ID: 12881394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I dose-escalation trial of afatinib, an irreversible ErbB family blocker, in combination with gemcitabine or docetaxel in patients with relapsed or refractory solid tumors.
    Hiret S; Isambert N; Gomez-Roca C; Bennouna J; Sassi M; de Mont-Serrat H; Fan J; Schnell D; Delord JP
    Invest New Drugs; 2018 Dec; 36(6):1044-1059. PubMed ID: 29808308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete regression of pulmonary squamous carcinoma in IPF following gemcitabine plus cisplatin: a case report and literature review.
    Ma W; Li H; Tian Z; Wang S; Zheng X; Hou J
    BMC Pulm Med; 2020 Mar; 20(1):69. PubMed ID: 32197657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of cardio-oncology.
    Nebigil CG; Désaubry L
    Ann Pharm Fr; 2018 Nov; 76(6):504-506. PubMed ID: 30075937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiotoxicity in oncology and coronary microcirculation: future challenges in theranostics.
    Peretto G; Lazzeroni D; Sartorio CL; Camici PG
    Front Biosci (Landmark Ed); 2017 Jun; 22(10):1760-1773. PubMed ID: 28410144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Case of Gemcitabine and Cisplatin Chemotherapy in a Patient With Metastatic Urothelial Carcinoma Receiving Hemodialysis.
    Ezaki T; Matsumoto K; Morita S; Shinoda K; Mizuno R; Kikuchi E; Oya M
    Clin Genitourin Cancer; 2016 Aug; 14(4):e413-6. PubMed ID: 26935998
    [No Abstract]   [Full Text] [Related]  

  • 19. Biliary tract cancer: a survey regarding the current oncological daily care practice in Germany.
    Sinn M; Bischoff S; Nehls O; Pelzer U; von Weizsäcker F; Kubicka S; Stieler JM; Caca K; Riess H
    Onkologie; 2012; 35(12):755-60. PubMed ID: 23207621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Camrelizumab versus placebo in combination with gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (CAPTAIN-1st): a multicentre, randomised, double-blind, phase 3 trial.
    Yang Y; Qu S; Li J; Hu C; Xu M; Li W; Zhou T; Shen L; Wu H; Lang J; Hu G; Luo Z; Fu Z; Qu S; Feng W; Chen X; Lin S; Zhang W; Li X; Sun Y; Lin Z; Lin Q; Lei F; Long J; Hong J; Huang X; Zeng L; Wang P; He X; Zhang B; Yang Q; Zhang X; Zou J; Fang W; Zhang L
    Lancet Oncol; 2021 Aug; 22(8):1162-1174. PubMed ID: 34174189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.